Research use only. Not for use in humans or animals. All products and information on this site are provided strictly for in-vitro laboratory research purposes. They are not for use in humans or animals, and are not drugs, foods, cosmetics, or medical devices.
What Is Retatrutide? A Research Peptide Overview
Retatrutide is a synthetic peptide studied as a triple agonist — it is designed to interact with three receptors at once: the GIP receptor, the GLP-1 receptor, and the glucagon receptor. That triple mechanism has made it a heavily discussed subject in metabolic-signaling research. This overview covers what retatrutide is, its molecular class, and how to verify research-grade material.
Retatrutide at a glance
| Property | Value |
|---|---|
| Name | Retatrutide (research designation LY3437943) |
| Class | Synthetic triple GIP / GLP-1 / glucagon receptor agonist |
| Type | Long-acting incretin-analog peptide |
| Appearance | White lyophilized powder |
The "triple agonist" concept
Earlier incretin research peptides act on one receptor (GLP-1) or two (GIP + GLP-1, as with tirzepatide). Retatrutide is studied as a single molecule that engages three receptor pathways. Researchers study how simultaneous signaling through GIP, GLP-1, and glucagon receptors differs from single- or dual-agonist signaling in cell and animal metabolic models.
What retatrutide is studied for
In laboratory and preclinical research, retatrutide is studied for:
- Incretin-receptor signaling — comparative pharmacology across GIP, GLP-1, and glucagon receptors.
- Energy-metabolism models — how triple-receptor engagement affects metabolic markers in animal models.
- Receptor-binding studies — affinity and selectivity characterization in vitro.
Retatrutide offered here is a research chemical for laboratory use only and is not for use in humans or animals.
Retatrutide vs tirzepatide vs semaglutide
The incretin research peptides are best understood by how many receptors they engage:
- Semaglutide — single agonist (GLP-1).
- Tirzepatide — dual agonist (GIP + GLP-1).
- Retatrutide — triple agonist (GIP + GLP-1 + glucagon).
For a side-by-side comparison of the two triple/dual agonists, see retatrutide vs tirzepatide →.
Retatrutide ships as a lyophilized (freeze-dried) powder. Researchers refer to the lot-specific COA and validated laboratory protocols for any handling observations.
How research-grade material is verified
Every batch that ships from a credible US supplier should arrive with a third-party Certificate of Analysis (COA) for that exact lot. Peptide Technologies publishes a COA on every batch and links it to a QR code on the vial. A complete COA reports:
- Identity — mass spectrometry (ESI-MS) confirming the observed mass matches the theoretical mass of the target sequence.
- Purity — reverse-phase HPLC, reported as percent peak area at a fixed wavelength (typically 220 nm). Research-grade material is ≥99% by area.
- Net content — gravimetric confirmation the vial holds the stated mass within tolerance.
- Endotoxin — LAL assay below research-grade thresholds.
If a vendor cannot show you a lot-specific COA, you cannot verify what is in the vial. Browse the full COA library →
How to source research-grade material
For laboratory research, sourcing quality comes down to a few checks:
- Lot-specific COA from an accredited, independent laboratory — not a generic marketing PDF.
- HPLC purity ≥99% by peak area, with the chromatogram shown.
- US synthesis and finishing, so the chain of custody is documented end to end.
- Cold-chain shipping for lyophilized material, so the product arrives stable.
Peptide Technologies meets each of these and publishes a third-party COA for every lot. Browse the public COA library →
FAQ
What is retatrutide?
Retatrutide is a synthetic peptide studied as a triple agonist of the GIP, GLP-1, and glucagon receptors. It is a research chemical used in metabolic-signaling research.
How is retatrutide different from tirzepatide?
Tirzepatide is a dual agonist (GIP + GLP-1). Retatrutide is a triple agonist that adds glucagon-receptor engagement to the same GIP + GLP-1 activity.
Is retatrutide a GLP-1 peptide?
Retatrutide engages the GLP-1 receptor as one of three targets; it is not a GLP-1-only agonist. It also engages the GIP and glucagon receptors.
How is retatrutide verified?
Research-grade retatrutide is verified by HPLC for purity, mass spectrometry for identity, and an LAL endotoxin assay, reported on a lot-specific third-party COA.
Is retatrutide a research chemical?
Yes. Retatrutide supplied by Peptide Technologies is a research chemical for laboratory use only and is not for use in humans or animals.